0001437749-24-023415.txt : 20240725 0001437749-24-023415.hdr.sgml : 20240725 20240725073031 ACCESSION NUMBER: 0001437749-24-023415 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240725 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240725 DATE AS OF CHANGE: 20240725 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ULTRALIFE CORP CENTRAL INDEX KEY: 0000875657 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690] ORGANIZATION NAME: 04 Manufacturing IRS NUMBER: 161387013 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-20852 FILM NUMBER: 241139811 BUSINESS ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 BUSINESS PHONE: 3153327100 MAIL ADDRESS: STREET 1: 2000 TECHNOLOGY PARKWAY CITY: NEWARK STATE: NY ZIP: 14513 FORMER COMPANY: FORMER CONFORMED NAME: ULTRALIFE BATTERIES INC DATE OF NAME CHANGE: 19940224 8-K 1 ulbi20240724_8k.htm FORM 8-K ulbi20240724_8k.htm
false 0000875657 0000875657 2024-07-25 2024-07-25
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
 
 
July 25, 2024
Date of Report (Date of Earliest Event Reported)
 
 
ULTRALIFE CORPORATION
(Exact name of registrant as specified in its charter)
 
Delaware
000-20852
16-1387013
(State of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
 
2000 Technology Parkway, Newark, New York 14513
(Address of principal executive offices) (Zip Code)
 
(315) 332-7100
(Registrant’s telephone number, including area code)
 
 
Securities registered pursuant to Section 12(b) of the Act:
 
Common Stock, $0.10 par value per share
ULBI
NASDAQ
(Title of each class)
(Trading Symbol)
(Name of each exchange on which registered)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
 
 

 
Item 2.02 Results of Operations and Financial Condition
 
On July 25, 2024, Ultralife Corporation issued a press release regarding the financial results for its second quarter ended June 30, 2024. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by this reference.
 
 
Item 9.01 Financial Statements, Pro Forma Financials and Exhibits
 
(d) Exhibits.
 
Exhibit
Number
 
Exhibit Description
 
99.1
   
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 
 

 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date: July 25, 2024
 
ULTRALIFE CORPORATION
 
       
       
 
By:
/s/ Philip A. Fain
 
   
Philip A. Fain
 
   
Chief Financial Officer and Treasurer
 
 
 
EX-99.1 2 ex_702594.htm EXHIBIT 99.1 ex_702594.htm

Exhibit 99.1

logo.jpg

 

 

Ultralife Corporation Reports Second Quarter Results

 

 

NEWARK, N.Y. – July 25, 2024 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2024 with the following highlights:

 

 

Sales of $43.0 million compared to $42.7 million for the 2023 second quarter, including 8.3% growth in Battery & Energy Products sales to its highest level in the Company’s history for this segment

 

Gross profit of $11.6 million, or 26.9% of revenue, compared to $10.6 million, or 24.8% of revenue, for the 2023 second quarter

 

Operating income of $3.9 million, a 6.9% increase over the 2023 second quarter

 

GAAP EPS of $0.18 compared to $0.21 which included recognition of our Employee Retention Credit equivalent to $0.07 per share for the 2023 second quarter

 

Adjusted EBITDA of $5.4 million or 12.6% of sales versus $6.3 million or 14.7% last year, which included $1.5 million for our Employee Retention Credit

 

Backlog of $93.0 million exiting the second quarter

 

Debt reduction of $13.2 million, or 52.2%, to $12.1 million from $25.3 million at the end of the first quarter

 

“Ultralife’s second quarter results testify to the continued high demand for our products particularly from our government/defense and medical battery customers, the success of our initiatives to improve Battery & Energy Products’ gross margin, and our solid cash flow generation which we used to reduce our debt by over 50%,” said Mike Manna, President and Chief Executive Officer.  “Looking ahead to the second half of the year, our main priorities remain driving gross margin increases through material cost deflation, lean productivity, scrap reduction and price realization for both businesses, and expanding the opportunity funnels and customer wins for larger projects. We are optimistic that we are well positioned to sustain profitable growth and generate incremental cash flow that can be allocated to debt reduction and investments in strategic capital expenditures and accretive acquisitions.”

 

 

Second Quarter 2024 Financial Results

 

Revenue was $43.0 million compared to revenue of $42.7 million for the second quarter of 2023. Battery & Energy Products sales increased 8.3% to $36.7 million, compared to $33.9 million last year, reflecting increases of 30.5% in government/defense sales and 20.1% in medical battery sales, partially offset by a 10.9% decrease in oil & gas market sales. Communications Systems sales decreased 28.7% to $6.3 million compared to $8.8 million for the same period last year, primarily attributable to shipments in the 2023 period for orders which had been previously delayed by supply chain disruptions. Our total backlog exiting the second quarter was $93.0 million.

 

Gross profit was $11.6 million, or 26.9% of revenue, compared to $10.6 million, or 24.8% of revenue, for the same quarter a year ago. Battery & Energy Products’ gross margin increased 480 basis points to 27.1%, compared to 22.3% last year, primarily due to higher cost absorption and more efficiencies resulting from our concerted effort to level-load production more evenly across the 2024 quarter, as well as improved price realization. Communications Systems gross margin was 25.6% compared to 34.5% last year, primarily due to product mix.

 

 

 

Operating expenses were $7.6 million, compared to $6.9 million for the 2023 second quarter, reflecting investments in new product development, the addition of sales resources to support future growth and executive bonus accruals which were not recognized in last year’s second quarter. Operating expenses were 17.8% of revenue compared to 16.2% of revenue for the year-earlier period.

 

Operating income was $3.9 million compared to $3.7 million last year. Driven by the 210-basis point gain in gross margin, operating margin increased to 9.1% compared to 8.6% last year.

 

Other income, reported below operating income, includes $0.2 million as a preliminary payment from our insurance carrier pertaining to the cyberattack which occurred in the first quarter of 2023. Other income for the second quarter of 2023 included an Employee Retention Credit (“ERC”) of $1.5 million under Section 2301 of the Coronavirus Aid, Relief and Economic Security Act of 2020 and the American Rescue Plan of 2021 which was filed with the Internal Revenue Service during that quarter.

 

Net income was $3.0 million, or $0.18 per diluted share on a GAAP basis, compared to net income of $3.3 million or $0.21 per diluted share for the second quarter of 2023. Adjusted EPS was $0.22 on a diluted basis for the second quarter of 2024, compared to $0.29 for the 2023 period. Adjusted EPS excludes the provision for deferred taxes which primarily represents non-cash charges for U.S. taxes which we expect will be fully offset by net operating loss carryforwards and other tax credits for the foreseeable future. Recognition of the ERC in the second quarter of 2023 increased GAAP and Adjusted EPS by $0.07 and $0.10, respectively, for that period.

 

Adjusted EBITDA, defined as EBITDA including non-cash, stock-based compensation expense, was $5.4 million for the second quarter of 2024, or 12.6% of sales, compared to $6.3 million, or 14.7% of sales, for the year earlier period which included the ERC.

 

See the “Non-GAAP Financial Measures” section of this release for a reconciliation of adjusted EPS to EPS and adjusted EBITDA to net income attributable to Ultralife Corporation.

 

 

 

About Ultralife Corporation

 

Ultralife Corporation serves its markets with products and services ranging from power solutions to communications and electronics systems. Through its engineering and collaborative approach to problem solving, Ultralife serves government/defense and commercial customers across the globe.

 

Headquartered in Newark, New York, the Company's business segments include Battery & Energy Products and Communications Systems. Ultralife has operations in North America, Europe and Asia. For more information, visit www.ultralifecorporation.com.

 

 

Conference Call Information

 

Ultralife will hold its second quarter earnings conference call today at 8:30 AM ET.

 

To ensure a fast and reliable connection to our investor conference call, we now require participants dialing in by phone to register using the following link prior to the call: https://register.vevent.com/register/BI3ab77e4ff3d049f3b130d6d227043bba. This will eliminate the need to speak with an operator. Once registered, dial-in information will be provided along with a personal identification number. Should you register early and misplace your details, you can simply click back on this same link at any time to register and view this information again. A live webcast of the conference call will be available to investors in the Events & Presentations section of the Company's website at http://investor.ultralifecorporation.com. For those who cannot listen to the live broadcast, a replay of the webcast will be available shortly after the call at the same location.

 

This press release may contain forward-looking statements based on current expectations that involve a number of risks and uncertainties. The potential risks and uncertainties that could cause actual results to differ materially include uncertain global economic conditions, reductions in revenues from key customers, delays or reductions in U.S. and foreign military spending, acceptance of our new products on a global basis, and disruptions or delays in our supply of raw materials and components due to business conditions, global conflicts, weather or other factors not under our control. The Company cautions investors not to place undue reliance on forward-looking statements, which reflect the Company's analysis only as of today's date. The Company undertakes no obligation to publicly update forward-looking statements to reflect subsequent events or circumstances. Further information on these factors and other factors that could affect Ultralife’s financial results is included in Ultralife’s Securities and Exchange Commission (SEC) filings, including the latest Annual Report on Form 10-K.

 

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(Dollars in Thousands)

(Unaudited)

 

ASSETS

                 
   

June 30,

2024

   

December 31,

2023

 

Current Assets:

               

Cash

  $ 6,690     $ 10,278  

Trade Accounts Receivable, Net

    31,055       31,761  

Inventories, Net

    41,392       42,215  

Prepaid Expenses and Other Current Assets

    4,650       5,949  

Total Current Assets

    83,787       90,203  
                 

Property, Plant and Equipment, Net

    20,281       21,117  

Goodwill

    37,510       37,571  

Other Intangible Assets, Net

    14,646       15,107  

Deferred Income Taxes, Net

    9,088       10,567  

Other Non-Current Assets

    4,505       3,711  
                 

Total Assets

  $ 169,817     $ 178,276  
                 

LIABILITIES AND SHAREHOLDERS' EQUITY

                 

Current Liabilities:

               

Accounts Payable

  $ 9,691     $ 11,336  

Current Portion of Long-Term Debt

    2,000       2,000  

Accrued Compensation and Related Benefits

    2,312       3,115  

Accrued Expenses and Other Current Liabilities

    6,570       7,279  

Total Current Liabilities

    20,573       23,730  

Long-Term Debt, Net

    9,978       23,624  

Deferred Income Taxes

    1,642       1,714  

Other Non-Current Liabilities

    4,279       3,781  

Total Liabilities

    36,472       52,849  
                 

Shareholders' Equity:

               

Common Stock

    2,106       2,078  

Capital in Excess of Par Value

    191,388       189,160  

Accumulated Deficit

    (34,894 )     (40,754 )

Accumulated Other Comprehensive Loss

    (3,895 )     (3,660 )

Treasury Stock

    (21,492 )     (21,492 )

Total Ultralife Equity

    133,213       125,332  

Non-Controlling Interest

    132       95  

Total Shareholders’ Equity

    133,345       125,427  
                 

Total Liabilities and Shareholders' Equity

  $ 169,817     $ 178,276  

 

 

 

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands Except Per Share Amounts)

(Unaudited)

 

   

Three-Month Period Ended

   

Six-Month Period Ended

 
   

June 30,

   

June 30,

   

June 30,

   

June 30,

 
   

2024

   

2023

   

2024

   

2023

 

Revenues:

                               

Battery & Energy Products

  $ 36,683     $ 33,861     $ 71,672     $ 62,331  

Communications Systems

    6,300       8,831       13,238       12,277  

Total Revenues

    42,983       42,692       84,910       74,608  
                                 

Cost of Products Sold:

                               

Battery & Energy Products

    26,730       26,318       52,733       48,276  

Communications Systems

    4,690       5,786       9,144       8,308  

Total Cost of Products Sold

    31,420       32,104       61,877       56,584  
                                 

Gross Profit

    11,563       10,588       23,033       18,024  
                                 

Operating Expenses:

                               

Research and Development

    1,997       1,778       3,753       3,810  

Selling, General and Administrative

    5,649       5,145       11,300       10,523  

Total Operating Expenses

    7,646       6,923       15,053       14,333  
                                 

Operating Income

    3,917       3,665       7,980       3,691  
                                 

Other (Expense) Income

    (71 )     1,058       (527 ))     564  

Income Before Income Taxes

    3,846       4,723       7,453       4,255  
                                 

Income Tax Provision

    853       1,375       1,556       1,242  
                                 

Net Income

    2,993       3,348       5,897       3,013  
                                 

Net Income Attributable to Non-Controlling Interest

    24       8       37       19  
                                 

Net Income Attributable to Ultralife Corporation

  $ 2,969     $ 3,340     $ 5,860     $ 2,994  
                                 
                                 

Net Income Per Share Attributable to Ultralife Common Shareholders Basic

  $ .18     $ .21     $ .36     $ .19  
                                 

Net Income Per Share Attributable to Ultralife Common Shareholders Diluted

  $ .18     $ .21     $ .35     $ .19  
                                 

Weighted Average Shares Outstanding Basic

    16,568       16,141       16,482       16,138  
                                 

Weighted Average Shares Outstanding Diluted

    16,825       16,144       16,661       16,141  

 

 

 

Non-GAAP Financial Measures

 

Adjusted EBITDA

 

In evaluating our business, we consider and use adjusted EBITDA, a non-GAAP financial measure, as a supplemental measure of our operating performance in addition to U.S. Generally Accepted Accounting Principles (“GAAP”) financial measures. We define adjusted EBITDA as net income attributable to Ultralife Corporation before net interest expense, provision (benefit) for income taxes, depreciation and amortization, and stock-based compensation expense, plus/minus expense/income that we do not consider reflective of our ongoing continuing operations. We reconcile adjusted EBITDA to net income attributable to Ultralife Corporation, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EBITDA as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EBITDA to net income attributable to Ultralife Corporation.

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EBITDA

(Dollars in Thousands)

(Unaudited)

 

   

Three-Month Period Ended

   

Six-Month Period Ended

 
   

June 30,

2024

   

June 30,

2023

   

June 30,

2024

   

June 30,

2023

 
                                 

Net Income Attributable to Ultralife Corporation

  $ 2,969     $ 3,340     $ 5,860     $ 2,994  

Adjustments:

                               

Interest Expense, Net

    418       440       938       864  

Income Tax Provision

    853       1,375       1,556       1,242  

Depreciation Expense

    789       760       1,529       1,522  

Amortization Expense

    227       227       455       436  

Stock-Based Compensation Expense

    159       154       320       293  

Cyber-Insurance Policy Deductible

    -       -       -       100  

Adjusted EBITDA

  $ 5,415     $ 6,296     $ 10,658     $ 7,451  

 

 

 

Adjusted Earnings Per Share

 

In evaluating our business, we consider and use adjusted EPS, a non-GAAP financial measure, as a supplemental measure of our business performance. We define adjusted EPS as net income attributable to Ultralife Corporation excluding the provision (benefit) for deferred income taxes divided by our weighted average shares outstanding on both a basic and diluted basis. We believe that this information is useful in providing period-to-period comparisons of our results by reflecting the portion of our tax provision that will be predominantly offset by our U.S. net operating loss carryforwards and other tax credits for the foreseeable future. We reconcile adjusted EPS to EPS, the most comparable financial measure under GAAP. Neither current nor potential investors in our securities should rely on adjusted EPS as a substitute for any GAAP measures and we encourage investors to review the following reconciliation of adjusted EPS to EPS and net income attributable to Ultralife Corporation.

 

ULTRALIFE CORPORATION AND SUBSIDIARIES

CALCULATION OF ADJUSTED EPS

(In Thousands Except Per Share Amounts)

(Unaudited)

 

   

Three-Month Period Ended

 
   

June 30, 2024

   

June 30, 2023

 
   

Amount

   

Per

Basic

Share

   

Per

Diluted

Share

   

Amount

   

Per

Basic

Share

   

Per

Diluted

Share

 

Net Income Attributable to Ultralife Corporation

  $ 2,969     $ .18     $ .18     $ 3,340     $ .21     $ .21  

Deferred Tax Provision

    744       .04       .04       1,278       .08       .08  

Adjusted Net Income

  $ 3,713     $ .22     $ .22     $ 4,618     $ .29     $ .29  
                                                 

Weighted Average Shares Outstanding

            16,568       16,825               16,141       16,144  

 

   

Six-Month Period Ended

 
   

June 30, 2024

   

June 30, 2023

 
   

Amount

   

Per

Basic

Share

   

Per

Diluted

Share

   

Amount

   

Per

Basic

Share

   

Per

Diluted

Share

 

Net Income Attributable to Ultralife Corporation

  $ 5,860     $ .36     $ .35     $ 2,994     $ .19     $ .19  

Deferred Tax Provision

    1,394       .08       .08       888       .05       .05  

Adjusted Net Income

    7,254     $ .44     $ .43     $ 3,882     $ .24     $ .24  
                                                 

Weighted Average Shares Outstanding

            16,482       16,661               16,138       16,141  

 

 

 

Company Contact:

Ultralife Corporation

Philip A. Fain

(315) 210-6110

pfain@ulbi.com

 

Investor Relations Contact:

LHA

Jody Burfening

(212) 838-3777

jburfening@lhai.com

 

 
EX-101.SCH 3 ulbi-20240725.xsd XBRL TAXONOMY EXTENSION SCHEMA 000 - Document - Document And Entity Information link:calculationLink link:definitionLink link:presentationLink EX-101.DEF 4 ulbi-20240725_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 5 ulbi-20240725_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity [Domain] Legal Entity [Axis] Document Information [Line Items] Document Information [Table] Document, Type Document, Period End Date Entity, Registrant Name Entity, Incorporation, State or Country Code Entity, File Number Entity, Tax Identification Number Entity, Address, Address Line One Entity, Address, City or Town Entity, Address, State or Province Entity, Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Entity, Emerging Growth Company Amendment Flag Entity, Central Index Key EX-101.PRE 6 ulbi-20240725_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE GRAPHIC 7 logo.jpg begin 644 logo.jpg M_]C_X 02D9)1@ ! 0$ 8 !@ #_VP!# ," @," @,# P,$ P,$!0@%!00$ M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_ MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04 M%!04%!04%!04%!04%!04%!04%!04%!3_P 1" O .X# 2( A$! Q$!_\0 M'P 04! 0$! 0$ $" P0%!@<("0H+_\0 M1 @$# P($ P4% M! 0 %] 0(# 01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D* M%A<8&1HE)B7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7& MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$ P$! 0$! M 0$! 0 $" P0%!@<("0H+_\0 M1$ @$"! 0#! <%! 0 0)W $" M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$ MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4 MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,! (1 Q$ /P#]4J,U#?74 M=G9S7$K!(HE,CL>P')K\S_V@?^"F7B/X/>/GT&TTV;5RT*W3>7+'$(%=F*(0 M8VR=H!_$4 ?IKN'K2[ATK\RO@'_P4.^(7[07C&XT#3M(FT@QVPD:\DEBF",\ MBQ1KM\H&K;19].^UEWEO9;F)T@B1"[N1Y(R !Z MBN7O/^"O?BV&\GCMM"O+BW1V$4WVB%3(N3AL>3QD<_C0!^P&X>M+D5^??PP_ M;(\<>.O@SJ?Q(U*230]-MH)IHX'\J0LB9!DW>6.OER*!C\Z^?/\ A[_XTQG_ M (1R\QV_TN'_ .,T ?L/FC(K\>/^'OWC0]/#MY_X%P__ !FC_A[YXT[^'KP? M]O-_!>E^%YKG2[J:^UO35U4VBSQ*;:)W98 M@S>3R65=W08!%Y_P"OR'_XS0!^Q.X4;A7Y :=_P5^\5)=H M;OP_?K#GYBMS Y'X&(9_,5][_LK?M:Z-^T;H$5S;.//9VBQY1B=)57>T4B'. MU@OS @D$=* /HC_:X\0_M M.7TNH:C'+IUI;7,VGR6,KQR;I!"DJ/N5%[%AC':O=_C=X\U'P;%;2V%Z]I'' M'YL_EHA:1F8*B_,#C^(_A0!ZYFC<.M?&5I^T]XBU+6K/2;2\OGN[J984+^1M M&2413L#?,I)W,&_*L#X:?M0>)_B1 MX9UOQ!'=7NGZ9IM(7 [U\.WO[66OV,+2OJ^H;5Y/R M6YX_[]U[+\$_'WBC7H]7U[Q7?S)I&FZ:EP\+1K\KNID.=JC)2-!^+T >_;AZ MTM>%?\+P\0C6S;_V+ K>8JC26!\\YA\\1^;OQYGE9./+V;AMW]Z]IT?5;?7- M)L]1M&WVMW"D\3$8RC*&!_(T 8'Q,U".S\(WL7LAB8KG$8.R,=/[JK7Z6?\ !2CXU/\ #SX7:U9V M5QY5Y_9QA1E;!6:Y8Q*?JJ!V_"OP^76M1CP!?7( Z#SF']: /U?_ ."=/@.' M1?#^H^+[JR%G+/<2W2JRX/E6J^7%_P!]3S9'_7,U\S_M7>)I/&7QOUV1-*EO M;33"NG02@ AM@RY'_ RU>]>#OVCO _P5_98L4M->M;O4/[.MDBA2=6EF*1ER MA7.[>]P[%LC@+7YCWGBS6-0O+FZFU&Z,MQ(\TA$SOJ: /K7X6:;-X6 M^&OQ$\9_V3);W7V6/P]IX5<,\MRO*H]-DEVQ1:$P=B(T4+W8X M 'XXI/B]KM_X-^#OPV\&I>7$=[<1R^(]0_>,'\R?"0@G/:-3P?6L_P#9AAF\ M3? JNL-#IVGLU[*]Y=;8\H,H#N.#\V#COB@#]:O#?[*-[XW_9WTOP=!-! MINB7%JD,C1SF*9T0J"!^Z=<,49O?>?6OD#]JC]E'PI^SKH<"VL]]K'B.:Y2% M;<3))"B%2[%L1*<@;?Q85^B^B?M;?!SP_HMCI]OXKMO(M($A0A<9"C&>O?%? MD9_P4.^-EY\0/C4(K.^D2"TB:X)AD(&Z8[E''I$(A^= ')^'/#,_B3Q!I>D0 MZ-Y4FH7<5J)64;8][8+'V R?PK[P_P"'9?A%O"D>O7&IZC!IQD6"XEMV6%0<%0%$<>/\ @3J?^ T ?EG\7M6C\5?$ M;6[NST6233(95L;'Y<@6L"B*+_QU ?QKVK]G_P#9E^'WCKX:OXH\>:G-H$TE MW*MO;PWT,&RW3"[V#*22S!\>H6O@.SU36KZZ@M8;^\>::18D03/DL2 !U]37 ML7[6>GR>#_&_AO1+:>14T[PY9VI97/S,N_>?Q8M^= &EK6@QV>L:C!I^ERWF MGPW$BVUVP53+$&(60X/!*\U]9_L:ZY)\%?"6H>+KVV_LV&6>2\CA?J52%X8W MQW):1R!WVCUKY!_9'\.>'_&WCR[_ .$NN9GL;*$7"JS-(A.3]Z,$>820H"D@ M9;)X&*F_:9_: F\>ZM%XEMR\;!?M,P^7=\O&Q1\J@<=3W& #LOC M9\2_$'QI\=7?B/7-'NI/^6=I;.I;R(L\(/\ :)Y/J3["LWXF?#&Z^&>H:3IM M]I:W-_=:;%?7*0)E('G-;-IY?4K*Y17&W=NBN(F(_P#'1^(KZ%_:F^) 75$LX(VN M!*[2MM&0$3]VGYG<:_,C]A/XJZCX/^*E].US).3:I*B2.3EXY5*_^A&NH^+G MQRUC7_%^HSQ:A.L4;B"/9(0-J<$C\=QH ^O_ -GNPE\:>.)F-MY(C5;.$D?\ MM9SL8CV6(2L?QK]!M7NH]!T.65,)'!%MC7\-J@?C@5^:?["_Q<\,_#VUBUCQ MOKGDLXENH5?,KF1_W: @= L8;K_ST->Z?M'?MJ>$+[X=W">#]5^V7D6Z>7Y" MA4*"$Z])/&.O0WP(@>&S7]S$$^7"_NCGG/ M.>I-3^(+/0?@[\,O#GA'PN+NZTZ[WZJ9;S_7RB0_(S_*.N3VZ**^(--^(6O> M*/$>G:7_ &I.%JU&Z<=E?1?(^GO!=IX?UZ2\D\3:K=:' F MT6Z6^*-3&FZ=XJURYNGC:0)Y"*-HQDDM M&!W'UKY+\!_"GXO_ !3T>'5/#M]=7T311R2Q6\,TS0!P60.5& 2.<>]>L?#S MP3\2_@!I_B'Q3XVM-2$ @51=36TL<4"*2Q&YP.6(7IZ8K0\T]$^+6L6^DZQ! MX=TJW>6QT6TCL(7/.6QEV..^2 ?I6;X3\/\ @C4-#BN?$GB'5--U61VWVME: M%XXES\@W&,Y8@9//<5\:W_QB\1>)-:9UU&476H7)8LSD*K.^ /&#NVBZSK6LO;W$$1MY8D@CED=AMCW&+.#C)Q MT!K[!\,^!DLO"NJZ7J:0LVJ--]LCMF.P(Z[-@) /" #./6OAK]B/Q!8Z!XLT M;1]=UI=5OI+J:6-[4-,L]T_R1KTRJJFYLGH17Z,KWH \4A^#>NVFI/<07MA% M?N[1GQ("WVPP-$D)0P[-I;9&G)?&X;L=J]@T72K?0](LM.LU*6MI"D$2GDA5 M4*/T%7-H/44M 'PK_P %#/V;M5^*&CZE=VIF;3[V.!FGAC,GV.XAR%,BCDQL MN,L.A%?DMX@_9G^(^AW+QCPW/J<*G"W.F%;B-_<;>?S -?THE0:Y?5_A7X.U MZ=I]0\,:5=3L6 5)9ONMS@;$R3ZBOVIL?@WX%TV0/; M^$M'5QT9K1'(_P"^@:Z"]\-Z7J5BEE=Z=:W-G&P9+>:!'C5AT(4C&10!_/U\ M$A##>>&] ?SJS\1/@+\4_''CC M6]2)3)%A(LD1K][@!% 'H!7]!7_"NO"H8D>&M'!]K"+_XFC_A7 M7A7G_BFM'.?^G"+_ .)H _.W_@D_\ ]2\$W6J:MK]@;34X=\[PL0S(S#RXLD M9&=OG'&?X@:YS_@J-_PEWQ?\40^'?"6ESZO964ZQW,D#IL7R@3LY(Y+NQ_X M*_4;2?#NF:#YPTW3[73UF(:1;6!8@Q P"=H&>*I2^ _#EQ(\DV@:7-*[%VDD MLHF9F/)))7DT ?@?^SY^R_XW/Q@\,MKOAZ:QLH[I'5YF0AILXB3 ))RY4_05 MUW[:7P(\8>)OCA?MX;T.XU73;*!;+[3&Z %HW<'.6'/2OW#MO OAVSN(Y[?0 M=,MYHVWI)%9QJRMZ@A>#[TR;X?\ ABXG>:;PYI,LKDL\CV,19B3DDDKR: /Y MX/#OP9^+?A.VU6"Q\,W=O_:5O]EFD5X]XCW L%.[@G&,^A-,\(?LN^.M9\26 M-EJ6B7&F6$LJK+<,R,0.RJ 22YZ >I%?T0?\*Y\)]_#&C'_N'P__ !-.A^'W MABUN(YX/#VE6\T;!DDBL8E92#D$$+D&@#YF^&'_!/GP#I_@/1;7Q+8W4NK16 MZK)';W)2. =HE '\(QD]2>!?#FI7DMU>:#IEW<2'+RSV4;NQQCDE,L&0X9D(7/S?WL?E703?"OQ3(Q)TBX)[[B MOY]:_>G_ (5OX2_Z%?1?_!?#_P#$TO\ PKGPG_T*^B_^"^'_ .)H _ F3X2> M)VS_ ,2>;!ZDE/\ &MK2OACKNF^'[Q/[+E^UWDZ!HQMR(D4D9Y[LWZ5^[9^& M_A(C'_"+Z*/^X?#_ /$T#X;^$A_S+&C'_N'P_P#Q- 'X=>!/AWK.AZI=ZK/8 M3++:VSFUC;&9)B-H Y]"U*K^?X;W7Y<9_.H7^%_B5NNCR@#M\O^ M-?O]_P *W\)_]"QHO_@OA_\ B:4_#GPG_P!"QHW_ (+X?_B: /SM_P""8_P? MEM?&4FIWL 0Z/:27+J0/EN9SL0''<1JY]LU^F8&,UGZ1X=TO0/-&F:=::<). 376T@2(,?4[0,UHT %%%% '__V0$! end XML 9 R1.htm IDEA: XBRL DOCUMENT v3.24.2
Document And Entity Information
Jul. 25, 2024
Document Information [Line Items]  
Entity, Registrant Name ULTRALIFE CORPORATION
Document, Type 8-K
Document, Period End Date Jul. 25, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 000-20852
Entity, Tax Identification Number 16-1387013
Entity, Address, Address Line One 2000 Technology Parkway
Entity, Address, City or Town Newark
Entity, Address, State or Province NY
Entity, Address, Postal Zip Code 14513
City Area Code 315
Local Phone Number 332-7100
Title of 12(b) Security Common Stock
Trading Symbol ULBI
Security Exchange Name NASDAQ
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0000875657
EXCEL 10 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( ,\[^5@'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #/._E8P\G1)? K @ $0 &1O8U!R;W!S+V-O&ULS9+/ M3L,P#(=?!>7>NDWY(Z(N%Z:=0$)B$HA;E'A;1--&B5&[MR<-6R<$#\ Q]B^? M/TMNM1=Z"/@'E_RNH7M M(ZE>8_H5K:"CQQ4[3WYM'M;;#9.\XM=%=5?PFVU=BZ82_/Y]=OWA=Q%V@[$[ M^X^-SX*RA5]W(;\ 4$L#!!0 ( ,\[^5B97)PC$ 8 )PG 3 >&PO M=&AE;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$ M[4X?A1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4 M\GA@V2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6 M:\?1TDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+ MTHMP' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3 M:W?=TXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ M %AP=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ W MQ-%,4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYK ME']IJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6? MR"VZY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^: M/5>A6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SCFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B" MP#E_+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE"0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F M.$KTL@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1 MN0K34I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/ MPT.'>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,K MD*)\3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5; M\K"^:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;Z MEW?!8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX# M7N83+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1 M/TL'?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO M0=5 Y3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% M @ SSOY6*FFF1U#! FA !@ !X;"]W;W)KA7#C#?GYOIH9]F9F8"S931&=)0M7^ MEL5R-W!\YW1CSC=;8V^XPWY*-VS!S',Z4W#E%BH13YC07 JBV'K@C/R;VZ!E M _(1?W"VTV?GQ$YE)>6+O9A$ \>S1"QFH;$2% ZO;,SBV"H!Q[]'4:=XI@T\ M/S^I/^23A\FLJ&9C&7_CD=D.G)Y#(K:F66SFO\+]D=QK;: M#@DS;61R# :"A(O#D;X=$W$6 !.M#@B. 4'.?7A03GE'#1WVE=P194>#FCW) MIYI' QP7MBH+H^!7#G%F>"?##))LR$A$Y%X8;O9D(@[5AJSU70,/L4/=\"AX M>Q ,WA'\/8NO2="^(H$7M/X?[@); 1@4@$&NUZP#/*,B?S_"*#(Q+-'_5"$> M)%O5DK;1;W1*0S9PH),U4Z_,&7[XR>]XOR+ S0*XB:D/#TF\(G.VX=HH"NA3 MFK J3%SH^7$Y'SU.'N[)^&D^>YJ/EI.G*0+8*@!;J.XIHU=DN4\KN?#X7N,S M0M$N*-H74LR8XM(V7T2@A2N!<*FBY>IZKE.P=2XJX42$4J52Y4UW118&\(A4 M9"PS8=0>CE$E+JY^=X\@=@O$[D6(#SQF9)HE*Z:J2' 1S_,:@==K!PA0KP#J M702TI&]D$D%A^9J'A[?U?3QS)1\Y2*L3&6-Z/1/C*U<+'S4VK]GFTEM:$S^XNF[;VN- MI-]JHPWHEPN#CQMZ7L(1?#N]CX(+-/TV!E(N #[NX(\RA)S,ME)@WE$CTFP& MC:[O>1A1N1CXN(4ON0$?DVOB!S^O?B$+%F8*LE6)A2N-99* YRR,#-%V+]<" M'[?KI:(1%QNRV"5[]X-7JU9*63![CI M?D?0/G>R&=6G2!<"[YIO%ZWW6EW MJ]#=1?,61TVPH<+(]-\\[F2!K:R^>F64>@N.P!^ M7TMI3A=V/UO\.V+X'U!+ P04 " #/._E8GZ ;\+$" #B# #0 'AL M+W-T>6QEO%D MN7/ZZZ>S;"=I=67=A['-HN6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY# M;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F? M KP(&K XU7=>&18/QA<0 M&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH M!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)? MA+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+ M"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TU MMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PEY7>>9 ]IV03NA1.XJRY/K% M.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD\%G'!QR>(W?#$T%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$# M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@" MIQ%', ; 4/2='@//GL?)=-[*CG_5U/\!%!+ P04 " #/._E8EXJ[', M 3 @ "P %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">, ?0(8@S9?$6!/D! M5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]$%)I6M6X 4BV)8]I MSI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA-/E_G;@2=&A(E@6FD7)TZ(=I7\= MQ_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X 4$L#!!0 ( ,\[ M^5@ZJJ+G0 $ #P" / >&PO=V]R:V)O;VLN>&ULC5%=:\,P#/PKQC]@ M20SH\0RVT+E6J:'3"T4\ M4V#C-E4DYPH]&09;B(S5'WC3B?PT9>H1-N6'$2&%GN5"6&-,W&_T_$8T'D&6 MA^[ ](2.(2X-PW.D0XMAU]&(B^S"1I_#6(<0Y_$_,5)=8P5+J@X> @\Y1G"= MP) :;)-6P7@H]+BB[H-5CX$E)+4* Y7L=D[E],H.KEGD7F08YRB#N+*#\%&M MA1H#V#:;7-Y-;2>C@W(-@[^&5C!W-CQ]W]P-02P,$% M @ SSOY6"0>FZ*M ^ $ !H !X;"]? M+7_OR4Z?:!1W;J"V\R1&:P;*9,OL[P"D6[2*+L[C,$]J%ZSB688&O-*]:A"2 M*+I!V#-DGNZ9HIP\_D-T==UI?#C]LCCP#S"\7>BI160I2A4:Y$S":+8VP5+B MRTR6HJ@R&8HJEG!:(.+)(&UI5GVP3TZTYWD7-_=%KLWC":[?#'!X=/X!4$L# M!!0 ( ,\[^5AED'F2&0$ ,\# 3 6T-O;G1E;G1?5'EP97-=+GAM M;*V334[#,!"%KQ)E6R4N+%B@IAM@"UUP 6-/&JO^DV=:TMLS3MI*H!(5A4VL M>-Z\SYZ7K-Z/$;#HG?78E!U1?!0"50=.8ATB>*ZT(3E)_)JV(DJUDUL0]\OE M@U#!$WBJ*'N4Z]4SM')OJ7CI>1M-\$V9P&)9/(W"S&I*&:,U2A+7Q<'K'Y3J M1*BY<]!@9R(N6%"*JX1<^1UPZGL[0$I&0[&1B5ZE8Y7HK4 Z6L!ZVN+*&4/; M&@4ZJ+WCEAIC JFQ R!GZ]%T,4TFGC",S[O9_,%F"LC*30H1.;$$?\>=(\G= M560C2&2FKW@ALO7L^T%.6X.^D&PO=&AE;64O=&AE;64Q+GAM;%!+ 0(4 Q0 ( ,\[^5BIIID=0P0 M )H0 8 " @0\( !X;"]W;W)K&PO&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'-02P$"% ,4 " #/._E899!Y MDAD! #/ P $P @ &?$@ 6T-O;G1E;G1?5'EP97-=+GAM 7;%!+!08 "0 ) #X" #I$P ! end XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 12 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 14 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.2 html 1 22 1 false 0 0 false 0 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.ulbi.com/20240725/role/statement-document-and-entity-information Document And Entity Information Cover 1 false false All Reports Book All Reports ulbi-20240725.xsd ulbi-20240725_def.xml ulbi-20240725_lab.xml ulbi-20240725_pre.xml ulbi20240724_8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 16 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "ulbi20240724_8k.htm": { "nsprefix": "ulbi", "nsuri": "http://www.ulbi.com/20240725", "dts": { "schema": { "local": [ "ulbi-20240725.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/currency/2023/currency-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/exch/2023/exch-2023.xsd", "https://xbrl.sec.gov/sic/2023/sic-2023.xsd", "https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" ] }, "definitionLink": { "local": [ "ulbi-20240725_def.xml" ] }, "labelLink": { "local": [ "ulbi-20240725_lab.xml" ] }, "presentationLink": { "local": [ "ulbi-20240725_pre.xml" ] }, "inline": { "local": [ "ulbi20240724_8k.htm" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 26, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://www.ulbi.com/20240725/role/statement-document-and-entity-information", "longName": "000 - Document - Document And Entity Information", "shortName": "Document And Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ulbi20240724_8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "d20248K", "name": "dei:EntityRegistrantName", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "div", "body", "html" ], "reportCount": 1, "baseRef": "ulbi20240724_8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationLineItems", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_DocumentInformationTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentInformationTable", "lang": { "en-us": { "role": { "label": "Document Information [Table]", "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Document, Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityDomain", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity [Domain]", "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Entity, Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LegalEntityAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LegalEntityAxis", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Legal Entity [Axis]", "documentation": "The set of legal entities associated with a report." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.ulbi.com/20240725/role/statement-document-and-entity-information" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 17 0001437749-24-023415-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001437749-24-023415-xbrl.zip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end XML 18 ulbi20240724_8k_htm.xml IDEA: XBRL DOCUMENT 0000875657 2024-07-25 2024-07-25 false 0000875657 8-K 2024-07-25 ULTRALIFE CORPORATION DE 000-20852 16-1387013 2000 Technology Parkway Newark NY 14513 315 332-7100 Common Stock ULBI NASDAQ false false false false false